等待開盤 05-18 09:30:00 美东时间
0.000
0.00%
EyePoint's late-stage eye drug trials to continue after safety panel review May 14 (Reuters) - EyePoint EYPT.O said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the studies continue unchanged.
05-14 20:35
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Eyepoint Pharma (($EYPT)) has held its Q1 earnings call. Read on for the main h...
05-08 10:20
RBC Capital analyst Lisa Walter maintains EyePoint (NASDAQ:EYPT) with a Outperform and lowers the price target from $39 to $37.
05-08 01:36
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
05-06 07:00
Ocular Therapeutix press release (OCUL): Q1 GAAP EPS of -$0.40 misses by $0.07. Revenue of $10.8M (+0.9% Y/Y) misses by $1.9M. Cash balance of $666.7 million as of March 31, 2026, with expected runway...
05-05 19:12
Insiders have been trading these 5 stocks: (($GLBE)), (($EYPT)), (($IMVT)), (($...
04-25 21:01
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:19